Plavix: A Significant Decision For Patent Holders

Law360, New York (November 18, 2008, 12:00 AM EST) -- In a significant decision, the Supreme Court of Canada (Apotex Inc. v. Sanofi-Synthelabo Canada et al (2008 SCC 61)) upheld pharmaceutical selection patents but defined potentially more stringent tests for anticipation and obviousness.

The decision has given pharmaceutical companies reason to breath a cautious sigh of relief, although there was actually little doubt that selection patents as a concept would be upheld.

However, the Court also signaled a shift in Canada's approach to obviousness which brings Canada into closer alignment with the more flexible (and usually...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.